Cat.#: ACPP-1286
| Despition | Bestrophin 2 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1588 | Human GABARAP Protein (AC1588) | 10 µg | inquiry |
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
| ACPP-1619 | Mouse CRYAB Protein (AC1619) | 5 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
| ACPP-1421 | Human il-6 Protein, HEK (AC1421) | 2 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1792 | Rat CALB1 Protein (AC1792) | 1 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.